Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts - Wikidata - awgldk - TriplyDB

Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts

Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts

http://www.wikidata.org/entity/Q40445455

about

The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1 The relationship between nutrition and prostate cancer: is more always better?Lipid metabolic reprogramming in cancer cells Molecular pathways involved in prostate carcinogenesis: insights from public microarray datasets SR-BI: Linking Cholesterol and Lipoprotein Metabolism with Breast and Prostate Cancer Nutrition, dietary interventions and prostate cancer: the latest evidence Statins impair antitumor effects of rituximab by inducing conformational changes of CD20 Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites The expression profile of phosphatidylinositol in high spatial resolution imaging mass spectrometry as a potential biomarker for prostate cancer Hypertriglyceridemia is a potential preoperative predictor for biochemical recurrence after radical prostatectomy Heparanase induces Akt phosphorylation via a lipid raft receptor The importance of LDL and cholesterol metabolism for prostate epithelial cell growth Ceramide mediates nanovesicle shedding and cell death in response to phosphatidylinositol ether lipid analogs and perifosine.Lipid metabolism emerges as a promising target for malignant glioma therapy.The potential effect of statins on rituximab immunotherapy.Rapid preparation of nuclei-depleted detergent-resistant membrane fractions suitable for proteomics analysis.Cytomegalovirus Restructures Lipid Rafts via a US28/CDC42-Mediated Pathway, Enhancing Cholesterol Efflux from Host Cells.Serum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC).Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence Statin use and prognosis in patients with diffuse large B-cell lymphoma and follicular lymphoma in the rituximab era Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle Cholesterol and benign prostate disease.Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol.Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model.Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo.Evaluation of atorvastatin efficacy and toxicity on spermatozoa, accessory glands and gonadal hormones of healthy men: a pilot prospective clinical trial Cholesterol selectively regulates IL-5 induced mitogen activated protein kinase signaling in human eosinophils A Class of Semiparametric Mixture Cure Survival Models with Dependent Censoring.In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin.Induction of apoptosis by the ginsenoside Rh2 by internalization of lipid rafts and caveolae and inactivation of Akt.Molecular genetics of prostate cancer: new prospects for old challenges High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors The bladder tumor suppressor protein TERE1 (UBIAD1) modulates cell cholesterol: implications for tumor progression.The response of the prostate to circulating cholesterol: activating transcription factor 3 (ATF3) as a prominent node in a cholesterol-sensing network Attenuation of astrogliosis and modulation of endothelial growth factor receptor in lipid rafts by simvastatin after traumatic brain injury.Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics Targeting cholesterol synthesis increases chemoimmuno-sensitivity in chronic lymphocytic leukemia cells.TRAMP prostate tumor growth is slowed by walnut diets through altered IGF-1 levels, energy pathways, and cholesterol metabolism.

P2860

Q24297392-88118097-4629-416F-8A68-F0801A5AD780 Q24604956-B3337C9D-D17D-4991-B449-F04916C89214 Q26774859-534A426D-E3EE-4A04-BB7B-BC433221AA31 Q27990300-F374ABA1-5DC4-4E0F-A1E2-2557E72A0949 Q28074790-5BA54F76-14AA-49CA-9083-DC2CEB845B13 Q28084566-F3C08868-08BF-4470-989C-17BDB21F1592 Q28472420-A1C43128-DCD9-4C73-90FC-F5B7432474F8 Q28478551-D7774EBF-7A76-42CC-B504-EE7FA2DBD2E6 Q28540259-A5A61DDD-6473-46E8-9790-DEDF70996E02 Q28544975-944CCC52-45F3-48C1-A69E-1AB4D49355B7 Q28590395-5BB5AFCD-A244-4214-9A33-9C1C9FC81EED Q28727920-464AA3DD-D6E3-4D0F-B23D-DF470A3BB7D6 Q30523059-63EADD59-3795-4131-BA4B-CE58C0FC78DB Q30684049-1F120CA9-28E3-41AD-8076-5F5D4F592B6F Q33325581-B364AD7A-0D12-461F-9C97-6A8296064086 Q33340838-D6C2EA76-7B91-4C92-BF8A-4811A16DFB9C Q33557172-B80691AF-8404-426F-9F9C-77CD3B53139A Q33564335-87C205B0-0F55-43E9-AC49-4D8E67C5F215 Q33579568-1816309D-B58A-4C2B-AD09-ABF9C2711F2A Q33627714-3C2B8373-9B34-46EA-8518-37FE12BD9ADA Q33715393-EDC303C3-0095-4E00-B8C2-410EB98D0B07 Q33732687-F9001B1C-3B44-4709-9584-831DC3D0012A Q33755491-46060CE7-39A0-4DE3-9AF6-7AFADC64994E Q33769607-B843C21D-3F92-4811-9FA4-7F2F8C01F2D3 Q33777669-1ABAE815-08EF-4CBA-921C-6AF7C149C70C Q33826605-20055044-19C6-4DDF-B9C4-109B433C3ACF Q33965084-9416B4F9-CA2E-4C39-BCD8-C8F5A48F7701 Q34046647-79CDDB67-C7D8-4D7B-AF0D-AE78344CA25E Q34060554-E5426E41-BC6F-46DE-9F6C-505CE6547F39 Q34092709-C1D25966-A232-41B5-BB45-EEFC30B4EFF9 Q34113016-1B3A939F-BD56-4C8A-9B14-019699E9BEA6 Q34127462-7BD5CA37-E2D4-46DF-B072-F045C5519A11 Q34137900-A56B3CB4-F6DF-4199-9455-794D621588AA Q34141720-B4E07A83-B6F2-489C-97E5-526179B4C159 Q34198892-0FC53A2F-D9F3-475B-AD42-860E1C5DCC62 Q34328954-97332D3A-C8D1-4C18-A294-21DD64FB5FC8 Q34430212-EB389168-F8C9-4C18-B86D-A22F24A541D7 Q34477513-BDD12F67-B031-4117-8045-11DD98BA3132 Q34507114-8FCEA8D7-23F3-444B-93E7-B35FE824C2F8 Q34652483-5F8AB60E-A96D-47A2-8DD1-2E4FEC4C9DCF

P2860

Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts

http://www.wikidata.org/entity/Q40445455

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Cholesterol targeting alters l ...... te cancer cells and xenografts

@en

type

label

Cholesterol targeting alters l ...... te cancer cells and xenografts

@en

prefLabel

Cholesterol targeting alters l ...... te cancer cells and xenografts

@en

P1433

Q40445455-2626EB43-89EA-48AC-92A5-B381F77EE79C

P1476

Q40445455-E6E7B580-D974-410F-BBEE-EE21FFFEA117

P2093

Q40445455-266DFCBF-BFDF-480E-B6B2-DEE708505EC0

Q40445455-3489F5F3-B39D-4BE7-8E92-7A3740877224

Q40445455-499B7C11-474F-4BB8-95C8-5FDB66EBB892

Q40445455-927738D9-3BF0-41A1-A45D-942C6C4FC7C0

Q40445455-D38A74B2-7B9F-44F6-83CD-4959E72BB0AA

P2860

Q40445455-06A4EAA4-7605-422C-A3AA-0F03BC32A785

Q40445455-08640410-F20F-41E3-8C01-D2CA95912250

Q40445455-089618F9-0E2F-4EEC-9360-375AF0ECB8DF

Q40445455-0F420425-5BBE-4F2E-8B04-2CBBA52E4276

Q40445455-100749B5-119B-4777-9031-AD34D7421884

Q40445455-1346F22E-795B-4056-9D8B-97F17193E618

Q40445455-14CDC83B-5209-43D9-A5F9-A7B894686E94

Q40445455-19EABC68-9241-4A86-807C-EB4A9FCAA0B5

Q40445455-1A0F9033-9E7C-46D9-BE7C-F0D5563EA079

Q40445455-1A19D6DD-5EDD-4A12-A536-46441C2A02B3

P304

Q40445455-CFBD4956-2DAB-423C-8F8F-656E570A5658

P31

Q40445455-C1A0CBF8-ED8D-4A57-8896-E568B12B8313

P356

Q40445455-1C3512D3-C2AB-4A45-869A-36F985826BB5

P407

Q40445455-D63CA127-AA25-4817-A1CD-AC22C30D0399

P433

Q40445455-80E3C405-C7E1-4DBD-94DB-3790FA989685

P478

Q40445455-1D60A205-7808-451D-9063-E5A21756291D

P577

Q40445455-588F827A-F3D5-4AD5-9F27-58F69B5AEDC3

P5875

Q40445455-2D742368-7B41-4A48-A302-4FD4C5A0747F

P698

Q40445455-1033B976-8026-4D6A-84FF-BA0E81E17388

P921

Q40445455-4E4C440F-73C8-4924-B014-B085F7333DF0

P932

Q40445455-76C66CF4-2C8E-442C-9982-19B146915309

P356

P1433

Journal of Clinical Investigation

P1476

Cholesterol targeting alters l ...... te cancer cells and xenografts

@en

P2093

Jayoung Kim

http://www.w3.org/2001/XMLSchema#string

Keith R Solomon

http://www.w3.org/2001/XMLSchema#string

Liyan Zhuang

http://www.w3.org/2001/XMLSchema#string

Michael R Freeman

http://www.w3.org/2001/XMLSchema#string

Rosalyn M Adam

http://www.w3.org/2001/XMLSchema#string

P2860

The sonic hedgehog receptor patched associates with caveolin-1 in cholesterol-rich microdomains of the plasma membrane

Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer

The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells

Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation

Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases

Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene

Role of translocation in the activation and function of protein kinase B

Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice

P304

959-968

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI19935

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7959060

http://www.w3.org/2001/XMLSchema#string

P698

15776112

http://www.w3.org/2001/XMLSchema#string

P921

P932

1064980

http://www.w3.org/2001/XMLSchema#string